Flannelly Barry P

EVP Barry P. Flannelly sold 19,807 shares at blended avg $67.69, reducing holding 37.1%; stock down 28.0% from 52-week high.

Barry P. Flannelly, EVP & General Manager US at Incyte, executed 3 separate sales on 2025-03-14 totaling 19,807 shares (19.8K shares) for $1,340,655.93 ($1.3M) at prices ranging from $67.68 to $67.88. This sale reduced his post-transaction holdings to 33,567 shares, a net reduction of 37.1% versus his pre-transaction position of 53,374 shares. The stock is currently trading at $60.00, down 28.0% from its 52-week high of $83.38 and down 14.8% over the past 30 days. His prior cross-ticker track record shows 1 prior sell with a 90-day well-timed rate of 0.00%, indicating his past sales have not consistently preceded declines; at Incyte specifically, his 1 prior sale on 2024-06-12 showed a positive 90-day return of 5.2%, meaning the stock rose after that sale. The current substantial reduction in stake and recent equity weakness warrant assessment of whether fundamental or operational factors are present.

EVP Barry P Flannelly sold 19,164 shares of INCY at $60.00 on 2024-06-12 for $1,149,840; holdings reduced to 66,377 shares

Barry P Flannelly, EVP & General Manager US at Incyte, executed a discretionary sale of 19,164 shares at $60.00, reducing his holdings by 22.4% from 85,541 shares to 66,377 shares. At the time of sale, the stock was trading above its 52-week low of $51.18 but approximately 9.9% below its 52-week high of $66.59. The company's fundamentals remain solid, with $880.9M in latest quarterly revenue, $169.5M in net income, 8.9% annual revenue growth, and a reasonable P/E of 18.71. Absent additional context on whether this sale was part of a planned trading schedule, the 22.4% reduction in executive holdings warrants monitoring to determine if it reflects portfolio rebalancing or a shift in executive assessment of the company's outlook.